Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Titel:
Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Auteur:
Diefenbach, Catherine Kahl, Brad S McMillan, Andrew Briones, Javier Banerjee, Lalita Cordoba, Raul Miall, Fiona Burke, John M Hirata, Jamie Jiang, Yanwen Paulson, Joseph N Chang, Yi Meng Musick, Lisa Abrisqueta, Pau